These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

942 related items for PubMed ID: 22650326

  • 1. Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.
    Guo B, Wu X, Zhang Y, Shi Y, Yu J, Cao G, Zhang J.
    Clin Drug Investig; 2012 Jul 01; 32(7):475-86. PubMed ID: 22650326
    [Abstract] [Full Text] [Related]

  • 2. Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers.
    Chung DT, Tsai CY, Chen SJ, Chang LW, King CH, Hsu CH, Chiu KM, Tan HC, Chang YT, Hsu MC.
    Antimicrob Agents Chemother; 2010 Jan 01; 54(1):411-7. PubMed ID: 19884374
    [Abstract] [Full Text] [Related]

  • 3. Dose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteers.
    Lin L, Chang LW, Tsai CY, Hsu CH, Chung DT, Aronstein WS, Ajayi F, Kuzmak B, Lyon RA.
    Antimicrob Agents Chemother; 2010 Jan 01; 54(1):405-10. PubMed ID: 19884368
    [Abstract] [Full Text] [Related]

  • 4. Safety, tolerability, and pharmacokinetics of intravenous nemonoxacin in healthy chinese volunteers.
    Cao GY, Zhang J, Zhang YY, Guo BN, Yu JC, Wu XJ, Chen YC, Wu JF, Shi YG.
    Antimicrob Agents Chemother; 2014 Oct 01; 58(10):6116-21. PubMed ID: 25092690
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of an Al(3+)- and Mg(2+)-containing antacid, ferrous sulfate, and calcium carbonate on the absorption of nemonoxacin (TG-873870) in healthy Chinese volunteers.
    Zhang YF, Dai XJ, Wang T, Chen XY, Liang L, Qiao H, Tsai CY, Chang LW, Huang PT, Hsu CY, Chang YT, Tsai CE, Zhong DF.
    Acta Pharmacol Sin; 2014 Dec 01; 35(12):1586-92. PubMed ID: 25327812
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre study.
    Li H, Butler K, Yang L, Yang Z, Teng R.
    Clin Drug Investig; 2012 Feb 01; 32(2):87-97. PubMed ID: 22168538
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and Safety of Tedizolid after Single and Multiple Intravenous/Oral Sequential Administrations in Healthy Chinese Subjects.
    Chen R, Shen K, Chang X, Tanaka T, Li L, Hu P.
    Clin Ther; 2016 Aug 01; 38(8):1869-79. PubMed ID: 27461846
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
    Wu H, Liu M, Wang S, Feng W, Yao W, Zhao H, Wei M.
    Clin Ther; 2010 Mar 01; 32(3):597-606. PubMed ID: 20399996
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Randomized Study of the Single-Dose Safety, Pharmacokinetics, and Food Effect of Chinfloxacin and Its Effect on Thorough QT/QTc Interval in Healthy Chinese Volunteers.
    Zhao C, Lv Y, Wei M, Li X, Hou F, Wang J, Ma X, Kang Z, Mao W, Liu Y, Xia Y, Tian J.
    Antimicrob Agents Chemother; 2018 Dec 01; 62(12):. PubMed ID: 30224529
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of vandetanib: three phase I studies in healthy subjects.
    Martin P, Oliver S, Kennedy SJ, Partridge E, Hutchison M, Clarke D, Giles P.
    Clin Ther; 2012 Jan 01; 34(1):221-37. PubMed ID: 22206795
    [Abstract] [Full Text] [Related]

  • 17. Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers.
    Kansagra KA, Parmar D, Jani RH, Srinivas NR, Lickliter J, Patel HV, Parikh DP, Heading H, Patel HB, Gupta RJ, Shah CY, Patel MR, Dholakia VN, Sukhadiya R, Jain MR, Parmar KV, Barot K.
    Clin Pharmacokinet; 2018 Jan 01; 57(1):87-102. PubMed ID: 28508936
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
    Liu Y, Jia J, Liu G, Li S, Lu C, Liu Y, Yu C.
    Clin Ther; 2009 Apr 01; 31(4):777-83. PubMed ID: 19446150
    [Abstract] [Full Text] [Related]

  • 19. Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers.
    Zhang YF, Dai XJ, Yang Y, Chen XY, Wang T, Tang YB, Tsai CY, Chang LW, Chang YT, Zhong DF.
    Drug Des Devel Ther; 2016 Apr 01; 10():357-70. PubMed ID: 26855561
    [Abstract] [Full Text] [Related]

  • 20. Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects.
    Chandra KP, Shiwalkar A, Kotecha J, Thakkar P, Srivastava A, Chauthaiwale V, Sharma SK, Cross MR, Dutt C.
    Clin Drug Investig; 2009 Apr 01; 29(9):559-75. PubMed ID: 19663519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.